Stay updated on Olaparib in BRCA Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Olaparib in BRCA Ovarian Cancer Clinical Trial page.

Latest updates to the Olaparib in BRCA Ovarian Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedA sitewide NIH notice about the terminology transition appears above the study record, and the site revision advances from v3.7.1 to v3.7.2. The study record itself remains a 403 error page.SummaryDifference1%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe footer identifies the site as revision v3.7.1 instead of v3.7.0.SummaryDifference0.2%

- Check38 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study details with an access-denied message.SummaryDifference17%

- Check45 days agoChange DetectedThe site version label was updated from v3.6.6 to v3.7.0, indicating a platform update that does not alter the trial information shown on the page.SummaryDifference0.0%

- Check59 days agoChange DetectedThe page's revision line now shows Revision: v3.6.6, replacing Revision: v3.6.5 in the metadata/footer. This reflects a minor version update in the page's maintenance metadata.SummaryDifference0.0%

- Check81 days agoChange DetectedThe revision label on the page was updated from v3.6.4 to v3.6.5, indicating a newer build of the site. This is a maintenance/update rather than a change to study content or user-facing features.SummaryDifference0.0%

Stay in the know with updates to Olaparib in BRCA Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Olaparib in BRCA Ovarian Cancer Clinical Trial page.